Stanton Chase Global Life Sciences and Healthcare Practice Revenues Rise 25%

Stanton Chase Global Life Sciences and Healthcare Practice Revenues Rise 25%
North American Practice Group Shows 75% Revenue Increase Alone

Austin, Texas, January 19, 2010

Global executive search firm Stanton Chase International announced today that the global Life Sciences and Healthcare revenues rose 25% for the 12 month period ending September 30, 2009. In addition, the number of global assignments increased by more than 6%.

The announcement was made by Life Sciences and Healthcare global practice leader David Harap, and comes in a time when earnings in the industry have been much lower than previous years.

"The significant growth we have seen in the Life Sciences and Healthcare was driven by a 60% increase in the number of CEO and COO assignments, while middle management searches dropped 30%," said Harap. "There was revenue growth in each of the four regions around the world, with North America revenue jumping 75%."

In North America, the Dallas, Austin and Baltimore offices showed the most growth and Germany led for the Europe, Middle East and Africa regions. Overall, there was an increase in general management searches and a decrease in searches for human resources and finance executives.

The Stanton Chase global Life Sciences and Healthcare practice has more than 65 consultants located in 40 countries around the world.

About Stanton Chase International

Stanton Chase is ranked within the top ten global retained executive search firms. With proven expertise in key sectors of the global economy, Stanton Chase has nine specialist practice groups that operate as international teams.

Stanton Chase is owned by its partners who take individual responsibility for delivering outstanding quality for each assignment. Stanton Chase is a member of the Association of Executive Search Consultants.

Back to latest news

• Latest news